Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best option for those looking for undervalued stocks?
The headline numbers for GE HealthCare (GEHC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GE HealthCare's Q3 results show steady revenue growth as strong imaging and diagnostics offset tariff and margin pressures.
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.14 per share a year ago.
GE HealthCare Technologies' said profit fell in the third quarter, weighed down by the added costs of tariffs.
GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.
GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.
Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?
U.S. medical device maker GE Healthcare is working with advisers to explore options for its China unit including an outright sale, a person with knowledge of the discussions said on Friday.
Medical device maker GE Healthcare is working with advisers to explore options including the sale of a stake in its China unit, Bloomberg News reported on Thursday, citing people familiar with the matter.